Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Compugen Ltd
About CGEN
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.
Find out what a historical investment in Compugen Ltd would be worth today using our CGEN stock calculator.
Market Capitalisation
$260.02M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
834.22K
High today
$2.95
Low today
$2.72
Open price
$2.95
52-week high
$3.24
52-week low
$1.29
Ready to start your investing journey with Stake?
Open an accountHow do I buy CGEN shares in Australia?
Buying CGEN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Compugen Ltd in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CGEN
What is the ticker symbol of Compugen Ltd?
The ticker symbol for Compugen Ltd is CGEN.
How much is one share of CGEN?
One share of CGEN is valued at $2.79 as of 17 May 2026.
What is the market capitalisation of Compugen Ltd CGEN?
As of 17 May 2026 Compugen Ltd has a market cap of $260.02M.
What is the P/E ratio of CGEN?
The Price to Earnings ratio of CGEN is 8.37.
What is the Earnings Per Share of CGEN?
The Earnings Per Share of CGEN is $0.36.
What is the 52-week high for Compugen Ltd stock?
The Compugen Ltd 52-week high stock price is $3.24.
What is the 52-week low for Compugen Ltd stock?
The Compugen Ltd 52-week low stock price is $1.29.
Can I buy CGEN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CGEN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CGEN on Stake
- Buy CGEN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CGEN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CGEN related stocks